Widely used:Recently Viewed
Clear All
Today’s Range
52 Week Range
Liquidity
Market cap
$----
P/E Ratio
--
P/B Ratio
--
Industry P/E
--
Debt to Equity
--
ROE
--
ROCE
--
Div. Yield
--
Book Value
--
EPS
--
CFO
$-14.55 Mln
EBITDA
$-52.75 Mln
Net Profit
$-95.45 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
PetVivo Holdings Inc. Warrant (PETVW)
| -81.71 | -- | -- | -92.24 | -67.81 | -- | -- |
|
BSE Sensex*
| 0.39 | 6.40 | 1.96 | 7.69 | 10.43 | 20.75 | 10.61 |
|
2023
|
|
|---|---|
|
PetVivo Holdings Inc. Warrant (PETVW)
| -44.11 |
|
BSE Sensex
| 18.74 |
|
BSE Sensex
| 18.74 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of... lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Edina, Minnesota. Read more
CEO, President & Director
Mr. John Lai
CEO, President & Director
Mr. John Lai
Headquarters
Edina, MN
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of PetVivo Holdings Inc Warrant (PETVW) is $0.03 (NASDAQ) as of 01-Oct-2024 13:50 EDT. PetVivo Holdings Inc Warrant (PETVW) has given a return of -67.81% in the last 3 years.
PetVivo Holdings Inc Warrant (PETVW) has a market capitalisation of -- as on 01-Oct-2024. As per Value Research classification, it is a company.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the PetVivo Holdings Inc Warrant (PETVW) and enter the required number of quantities and click on buy to purchase the shares of PetVivo Holdings Inc Warrant (PETVW).
PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Edina, Minnesota.
The CEO & director of Mr. John Lai. is PetVivo Holdings Inc Warrant (PETVW), and CFO & Sr. VP is Mr. John Lai.
There is no promoter pledging in PetVivo Holdings Inc Warrant (PETVW).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|
| PetVivo Holdings Inc. Warrant (PETVW) | Ratios |
|---|---|
|
Return on equity(%)
|
--
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
--
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of PetVivo Holdings Inc Warrant (PETVW) was $0 Mln.
$0.00
(
